32 related articles for article (PubMed ID: 11924802)
1. Comparative molecular genomic analyses of a spontaneous rhesus macaque model of mismatch repair-deficient colorectal cancer.
Ozirmak Lermi N; Gray SB; Bowen CM; Reyes-Uribe L; Dray BK; Deng N; Harris RA; Raveendran M; Benavides F; Hodo CL; Taggart MW; Colbert Maresso K; Sinha KM; Rogers J; Vilar E
PLoS Genet; 2022 Apr; 18(4):e1010163. PubMed ID: 35446842
[TBL] [Abstract][Full Text] [Related]
2. Urogenital Lesions in Nonhuman Primates at 2 National Primate Research Centers.
Kirejczyk S; Pinelli C; Gonzalez O; Kumar S; Dick E; Gumber S
Vet Pathol; 2021 Jan; 58(1):147-160. PubMed ID: 33208023
[TBL] [Abstract][Full Text] [Related]
3. Current status and evolution of preclinical drug development models of epithelial ovarian cancer.
Konstantinopoulos PA; Matulonis UA
Front Oncol; 2013 Dec; 3():296. PubMed ID: 24377084
[TBL] [Abstract][Full Text] [Related]
4. Spontaneously arising concurrent ileocaecal adenocarcinoma and renal pelvis transitional cell carcinoma in a rhesus macaque (Macaca mulatta).
Gumber S; Wood JS; Jones AC; Strobert E
J Comp Pathol; 2013 Nov; 149(4):524-8. PubMed ID: 24016782
[TBL] [Abstract][Full Text] [Related]
5. Biomarker modulation in a nonhuman rhesus primate model for ovarian cancer chemoprevention.
Brewer M; Utzinger U; Satterfield W; Hill L; Gershenson D; Bast R; Wharton JT; Richards-Kortum R; Follen M
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):889-93. PubMed ID: 11489756
[TBL] [Abstract][Full Text] [Related]
6. Combination of 4-HPR and oral contraceptive in monkey model of chemoprevention of ovarian cancer.
Brewer M; Ranger-Moore J; Satterfield W; Hao Z; Wang J; Brewer E; Wharton JT; Bast R; Zou C
Front Biosci; 2007 Jan; 12():2260-8. PubMed ID: 17127462
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical expression of molecular markers in an avian model: a potential model for preclinical evaluation of agents for ovarian cancer chemoprevention.
RodrÃguez-Burford C; Barnes MN; Berry W; Partridge EE; Grizzle WE
Gynecol Oncol; 2001 Jun; 81(3):373-9. PubMed ID: 11371125
[TBL] [Abstract][Full Text] [Related]
8. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer.
Brewer M; Wharton JT; Wang J; McWatters A; Auersperg N; Gershenson D; Bast R; Zou C
Gynecol Oncol; 2005 Aug; 98(2):182-92. PubMed ID: 15907982
[TBL] [Abstract][Full Text] [Related]
9. Fluorescence spectroscopy as a biomarker in a cell culture and in a nonhuman primate model for ovarian cancer chemopreventive agents.
Brewer M; Utzinger U; Li Y; Atkinson EN; Satterfield W; Auersperg N; Richards-Kortum R; Follen M; Bast R
J Biomed Opt; 2002 Jan; 7(1):20-6. PubMed ID: 11818008
[TBL] [Abstract][Full Text] [Related]
10. Rhesus macaque model for ovarian cancer chemoprevention.
Brewer M; Baze W; Hill L; Utzinger U; Wharton JT; Follen M; Khan-Dawood F; Satterfield W
Comp Med; 2001 Oct; 51(5):424-9. PubMed ID: 11924802
[TBL] [Abstract][Full Text] [Related]
11. Prevention of ovarian cancer.
Brewer MA; Mitchell MF; Bast RC
In Vivo; 1999; 13(1):99-106. PubMed ID: 10218141
[TBL] [Abstract][Full Text] [Related]
12. [Chemoprevention and prophylactic surgery in ovarian carcinoma].
Deffieux X; Touboul C; Uzan C; Faivre E; Frydman R; Fernandez H; Morice P
J Gynecol Obstet Biol Reprod (Paris); 2007 Dec; 36(8):756-63. PubMed ID: 17719183
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
